Results 71 to 80 of about 764 (131)

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

open access: yesCost Eff Resour Alloc
Jafari M   +6 more
europepmc   +1 more source

[Time trend of Family Health Strategy oral health teams in Brazilian municipalities from 2001 to 2021]. [PDF]

open access: yesCad Saude Publica
Menezes LXB   +4 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

open access: yesCost Eff Resour Alloc
Jafari M   +7 more
europepmc   +1 more source

Tooth loss in Brazilian adolescents: a multilevel cross-sectional study. [PDF]

open access: yesRev Bras Epidemiol
Lizardo LSC   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy